| A cell-based model of hemostasis M Hoffman, DM Monroe III Thrombosis and haemostasis 85 (06), 958-965, 2001 | 2215 | 2001 |
| Deficiency of protein C in congenital thrombotic disease. JH Griffin, B Evatt, TS Zimmerman, AJ Kleiss, C Wideman The Journal of clinical investigation 68 (5), 1370-1373, 1981 | 1911 | 1981 |
| Geographic distribution of the 20210 G to A prothrombin variant FR Rosendaal, CJM Doggen, A Zivelin, VR Arruda, M Aiach, DS Siscovick, ... Thrombosis and haemostasis 79 (04), 706-708, 1998 | 1016 | 1998 |
| The cytoprotective protein C pathway LO Mosnier, BV Zlokovic, JH Griffin Blood 109 (8), 3161-3172, 2007 | 983 | 2007 |
| Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation RJ Berckmans, R Nieuwland, AN Böing, FP Romijn, CE Hack, A Sturk Thrombosis and haemostasis 85 (04), 639-649, 2001 | 876 | 2001 |
| Endothelial and antithrombotic actions of HDL C Mineo, H Deguchi, JH Griffin, PW Shaul Circulation research 98 (11), 1352-1364, 2006 | 862 | 2006 |
| Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology TM Hackeng, JH Griffin, PE Dawson Proceedings of the National Academy of Sciences 96 (18), 10068-10073, 1999 | 842 | 1999 |
| Plasma protein S deficiency in familial thrombotic disease HP Schwarz, M Fischer, P Hopmeier, MA Batard, JH Griffin Blood 64 (6), 1297-1300, 1984 | 767 | 1984 |
| Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective T Cheng, D Liu, JH Griffin, JA Fernández, F Castellino, ED Rosen, ... Nature medicine 9 (3), 338-342, 2003 | 747 | 2003 |
| Anticoagulant protein C pathway defective in majority of thrombophilic patients JH Griffin, B Evatt, C Wideman, JA Fernandez Blood 82 (7), 1989-1993, 1993 | 713 | 1993 |
| Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme RA Marlar, AJ Kleiss, JH Griffin Blood 59 (5), 1067-1072, 1982 | 577 | 1982 |
| Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial Apex AMI Investigators Jama 297 (1), 43-51, 2007 | 566 | 2007 |
| Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant HE Branson, R Marble, J Katz, JH Griffin The Lancet 322 (8360), 1165-1168, 1983 | 476 | 1983 |
| Incidence of venous thromboembolism in families with inherited thrombophilia P Simioni, BJ Sanson, P Prandoni, D Tormene, PW Friederich, B Girolami, ... Thrombosis and haemostasis 81 (02), 198-202, 1999 | 458 | 1999 |
| Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V CA Fulcher, JE Gardiner, JH Griffin, TS Zimmerman Blood 63 (2), 486-489, 1984 | 449 | 1984 |
| Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. BN Bouma, JH Griffin Journal of Biological Chemistry 252 (18), 6432-6437, 1977 | 441 | 1977 |
| Activated protein C resistance caused by Arg506Gln mutation in factor Va JS Greengard, X Sun, X Xu, JA Fernandez, JH Griffin, B Evatt The Lancet 343 (8909), 1361-1362, 1994 | 436 | 1994 |
| Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII) JH Griffin Proceedings of the National Academy of Sciences 75 (4), 1998-2002, 1978 | 419 | 1978 |
| Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. JH Griffin, CG Cochrane Proceedings of the National Academy of Sciences 73 (8), 2554-2558, 1976 | 407 | 1976 |
| Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles G Tans, J Rosing, MC Thomassen, MJ Heeb, RF Zwaal, JH Griffin | 398 | 1991 |
